Nanoparticle-mediated delivery of oligonucleotides to the blood-brain barrier: in vitro and in situ brain perfusion studies on the uptake mechanisms

Journal of Drug Targeting

Volumn 21, Issue 9, 2013, Pages 866-873

  Ko, Young Tag ^a  

^a Gachon University   (South Korea)

Author keywords

Blood brain barrier; Brain targeting; Nanoparticles; Oligodeoxynucleotides

Indexed keywords

EARLY ENDOSOME ANTIGEN 1; NANOCARRIER; OLIGODEOXYNUCLEOTIDE; TRANSFERRIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY PERFUSION; ARTICLE; BLOOD BRAIN BARRIER; BRAIN PERFUSION; CELL MIGRATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; ENDOSOME; ENDOTHELIUM; ENDOTHELIUM CELL; FLUORESCENCE RESONANCE ENERGY TRANSFER; IN VITRO STUDY; INTERNAL CAROTID ARTERY; INTERNALIZATION; MALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CELL LINE; DRUG CARRIERS; ENDOCYTOSIS; ENDOTHELIAL CELLS; MICE; MICROSCOPY, CONFOCAL; NANOPARTICLES; OLIGONUCLEOTIDES; PERFUSION; PHOSPHOLIPIDS; POLYETHYLENEIMINE;

EID: 84885617369     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2013.829077     Document Type: Article

References (22)

1. Ko YT, Bhattacharya R, Bickel U. Liposome encapsulated polyethylenimine/ODN polyplexes for brain targeting. J Control Release 2009;133:230-7
2. Fischer D, Bieber T, Li Y, et al. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: Effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res 1999;16:1273-9
3. Kunath K, Von Harpe A, Fischer D, et al. Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: Comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine. J Control Release 2003;89:113-25
4. Morishita R, Sugimoto T, Aoki M, et al. In vivo transfection of cis element ''decoy'' against nuclear factor-kappaB binding site prevents myocardial infarction. Nat Med 1997;3:894-9
5. Zhang Y, Zhu C, Pardridge WM. Antisense gene therapy of brain cancer with an artificial virus gene delivery system. Mol Ther 2002; 6:67-72
6. Zhang Y, Pardridge WM. Delivery of beta-galactosidase to mouse brain via the blood-brain barrier transferrin receptor. J Pharmacol Exp Ther 2005;313:1075-81
7. Von Harpe A, Petersen H, Li Y, et al. Characterization of commercially available and synthesized polyethylenimines for gene delivery. J Control Release 2000;69:309-22
8. Ko YT, Bickel U, Huang J. Polyethylenimine/oligonucleotide polyplexes investigated by fluorescence resonance energy transfer and fluorescence anisotropy. Oligonucleotides 2011;21: 109-14
9. Bhattacharya R, Osburg B, Fischer D, et al. Targeted delivery of complexes of biotin-PEG-polyethylenimine and NF-kappaB decoys to brain-derived endothelial cells in vitro. Pharm Res 2008;25: 605-15
10. Wang J, Tian S, Petros RA, et al. The complex role of multivalency in nanoparticles targeting the transferrin receptor for cancer therapies. J Am Chem Soc 2010;132:11306-13
11. Juliano RL, Carver K, Cao C, et al. Receptors, endocytosis, and trafficking: The biological basis of targeted delivery of antisense and siRNA oligonucleotides. J Drug Target 2013;21:27-43
12. Cameron PL, Ruffin JW, Bollag R, et al. Identification of caveolin and caveolin-related proteins in the brain. J Neurosci 1997;17: 9520-35
13. Khawli LA, Prabhu S. Drug delivery across the blood-brain barrier. Mol Pharm 2013;10:1471-2
14. Iwasa A, Akita H, Khalil I, et al. Cellular uptake and subsequent intracellular trafficking of R8-liposomes introduced at low temperature. Biochim Biophys Acta 2006;1758:713-20
15. Kreuter J. Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (BBB). J Microencapsul 2013;30:49-54
16. Yang H. Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis. Pharm Res 2010;27:1759-71
17. Van Rooy I, Mastrobattista E, Storm G, et al. Comparison of five different targeting ligands to enhance accumulation of liposomes into the brain. J Control Release 2011;150:30-6
18. Qian ZM, Li H, Sun H, et al. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol Rev 2002;54:561-87
19. Shi N, Pardridge WM. Noninvasive gene targeting to the brain. Proc Natl Acad Sci USA 2000;97:7567-72
20. Shi N, Zhang Y, Zhu C, et al. Brain-specific expression of an exogenous gene after i.v. administration. Proc Natl Acad Sci USA 2001;98:12754-9
21. Kreuter J. Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 2001;47:65-81
22. Bickel U, Kang YS, Yoshikawa T, et al. In vivo demonstration of subcellular localization of anti-Transferrin receptor monoclonal antibody-colloidal gold conjugate in brain capillary endothelium. J Histochem Cytochem 1994;42:1493-7